SEARCH

SEARCH BY CITATION

References

  • Archer S. L., Gomberg-Maitland M., Maitland M. L., Rich S., Garcia J. G. and Weir E. K. (2008) Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am. J. Physiol. Heart Circ. Physiol. 294, H570H578.
  • Arumugam T. V., Chan S. L., Jo D. G. et al. (2006) Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nature Med. 12, 621623.
  • Bell E. L., Klimova T. A., Eisenbart J., Moraes C. T., Murphy M. P., Budinger G. R. and Chandel N. S. (2007) The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 177, 10291036.
  • Benjannet S., Elagoz A., Wickham L. et al. (2001) Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem. 276, 1087910887.
  • Borghi R., Patriarca S., Traverso N., Piccini A., Storace D., Garuti A., Cirmena G., Odetti P. and Tabaton M. (2007) The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. Neurobiol. Aging 28, 10091014.
  • Braak H., Braak E. and Bohl J. (1993) Staging of Alzheimer-related cortical destruction. Eur. Neurol. 33, 403408.
  • Chandel N. S., Maltepe E., Goldwasser E., Mathieu C. E., Simon M. C. and Schumacker P. T. (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl Acad. Sci. USA 95, 1171511720.
  • Chandel N. S., McClintock D. S., Feliciano C. E., Wood T. M., Melendez J. A., Rodriguez A. M. and Schumacker P. T. (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275, 2513025138.
  • Chu K., Jung K. H., Kim S. J. et al. (2008) Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain. Brain Res. 1207, 182192.
  • Collino M., Aragno M., Mastrocola R., Gallicchio M., Rosa A. C., Dianzani C., Danni O., Thiemermann C. and Fantozzi R. (2006) Modulation of the oxidative stress and inflammatory response by PPAR gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 530, 7080.
  • Faghihi M. A., Modarresi F., Khalil A. M., Wood D. E., Sahagan B. G., Morgan T. E., Finch C. E., St Laurent G. 3rd, Kenny P. J. and Wahlestedt C. (2008) Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase. Nature Med. 14, 723730.
  • Ferreiro E., Resende R., Costa R., Oliveira C. R. and Pereira C. M. (2006) An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol. Dis. 23, 669678.
  • Fukumoto H., Cheung B. S., Hyman B. T. and Irizarry M. C. (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 13811389.
  • Guzy R. D. and Schumacker P. T. (2006) Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 91, 807819.
  • Hardy J. (2006) Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal. J. Alzheimers Dis. 9, 151153.
  • Hirai K., Aliev G., Nunomura A. et al. (2001) Mitochondrial abnormalities in Alzheimer’s disease. J. Neurosci. 21, 30173023.
  • Holsinger R. M., McLean C. A., Beyreuther K., Masters C. L. and Evin G. (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer’s disease. Ann. Neurol. 51, 783786.
  • Jellinger K. A. (1998) The neuropathological diagnosis of Alzheimer disease. J. Neural Transm. Suppl. 53, 97118.
  • Jo D. G., Arumugam T. V., Woo H. N. et al. (2008) Evidence that γ-secretase mediates oxidative stress-induced β-secretase expression in Alzheimer’s disease. Neurobiol. Aging [Epub ahead of print] doi: DOI: 10.1016/j.neurobiolaging.2008.07.003.
  • Kao S. C., Krichevsky A. M., Kosik K. S. and Tsai L. H. (2004) BACE1 suppression by RNA interference in primary cortical neurons. J. Biol. Chem. 279, 19421949.
  • Lage J. M. (2006) 100 years of Alzheimer’s disease (1906–2006). J. Alzheimers Dis. 9, 1526.
  • Li Y. and Trush M. A. (1998) Diphenyleniodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun. 253, 295299.
  • Li R., Lindholm K., Yang L. B. et al. (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer’s disease patients. Proc. Natl Acad. Sci. USA 101, 36323637.
  • Li L., Zhang X., Yang D., Luo G., Chen S. and Le W. (2007) Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP. Neurobiol. Aging [Epub ahead of print] doi: DOI: 10.1016/j.neurobiolaging.2007.12.015.
  • Mattson M. P. (2002) Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer’s disease. J. Neurovirol. 8, 539550.
  • Meldrum D. R., Shenkar R., Sheridan B. C., Cain B. S., Abraham E. and Harken A. H. (1997) Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J. Mol. Cell. Cardiol. 29, 28492854.
  • Mowrer K. R. and Wolfe M. S. (2008) Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production. J. Biol. Chem. 283, 1869418701.
  • Murphy M. P., Hickman L. J., Eckman C. B., Uljon S. N., Wang R. and Golde T. E. (1999) Gamma-secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid beta peptides of varying length. J. Biol. Chem. 274, 1191411923.
  • Pasternak S. H., Callahan J. W. and Mahuran D. J. (2004) The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer’s disease: reexamining the spatial paradox from a lysosomal perspective. J. Alzheimers Dis. 6, 5365.
  • Pickford F., Masliah E., Britschgi M. et al. (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118, 21902199.
  • Reddy P. H. and Beal M. F. (2005) Are mitochondria critical in the pathogenesis of Alzheimer’s disease? Brain Res. Brain Res. Rev. 49, 618632.
  • Rezvani H. R., Dedieu S., North S., Belloc F., Rossignol R., Letellier T., De Verneuil H., Taïeb A. and Mazurier F. (2007) Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J. Biol. Chem. 282, 1641316422.
  • Roberds S. L., Anderson J., Basi G. et al. (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer’s disease therapeutics. Hum. Mol. Genet. 10, 13171324.
  • Schaeffer E. L. and Gattaz W. F. (2008) Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A(2) enzyme. Psychopharmacology 198, 127.
  • Selkoe D. J. (2001) Alzheimer’s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 3, 7580.
  • Sharp F. R. and Bernaudin M. (2004) HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 5, 437448.
  • Stockley J. H. and O’Neill C. (2007) The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer’s disease brain. Biochem. Soc. Trans. 35, 574576.
  • Sun J. and Trumpower B. L. (2003) Superoxide anion generation by the cytochrome bc1 complex. Arch. Biochem. Biophys. 419, 198206.
  • Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L. E. and Song W. (2006) Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl Acad. Sci. USA 103, 1872718732.
  • Tahirovic I., Sofic E., Sapcanin A., Gavrankapetanovic I., Bach-Rojecky L., Salkovic-Petrisic M., Lackovic Z., Hoyer S. and Riederer P. (2007) Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer’s disease and diabetes mellitus. J. Neural Transm. Suppl. 72, 235240.
  • Tamagno E., Bardini P., Obbili A. et al. (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10, 279288.
  • Tamagno E., Robino G., Obbili A., Bardini P., Aragno M., Parola M. and Danni O. (2003) H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp. Neurol. 180, 144155.
  • Tamagno E., Parola M., Bardini P. et al. (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92, 628636.
  • Tamagno E., Guglielmotto M., Aragno M. et al. (2008a) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J. Neurochem. 104, 683695.
  • Tamagno E., Guglielmotto M., Giliberto L., Vitali A., Borghi R., Autelli R., Danni O. and Tabaton M. (2008b) JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. Neurobiol. Aging [Epub ahead of print] doi: DOI: 10.1016/j.neurobiolaging.2007.12.015.
  • Tesco G., Koh Y. H., Kang E. L. et al. (2007) Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 54, 721737.
  • Thakur A., Wang X., Siedlak S. L., Perry G., Smith M. A. and Zhu X. (2007) c-Jun phosphorylation in Alzheimer disease. J. Neurosi. Res. 85, 166816673.
  • De La Torre J. C. (2008) Alzheimer’s disease prevalence can be lowered with non-invasive testing. J Alzheimers Dis. 14, 353359.
  • Turrens J. F. (2003) Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335344.
  • Tyler S. J., Dawbarn D., Wilcock G. K. and Allen S. J. (2002) Alpha- and beta-secretase: profound changes in Alzheimer’s disease. Biochem. Biophys. Res. Commun. 299, 373376.
  • Vassar R., Bennett B. D., Babu-Khan S. et al. (1999) Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.
  • Wallace D. C. (2001) Mouse models for mitochondrial disease. Am. J. Med. Genet. 106, 71793.
  • Wang R., Zhang Y. W., Zhang X., Liu R., Zhang X., Hong S., Xia K., Xia J., Zhang Z. and Xu H. (2006) Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J. 20, 12751277.
  • Yang L. B., Lindholm K., Yan R. et al. (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 34.
  • Yao S.-Y., Soutto M. and Sriram S. (2008) Bacterial cell wall products increases stabilization of HIF-1 alpha in an oligodendrocyte cell line preconditioned by cobalt chloride or desferrioxamine. J. Neuroimmunol. 200, 1726.
  • Yu W. H., Kumar A., Peterhoff C., Shapiro Kulnane L., Uchiyama Y., Lamb B. T., Cuervo A. M. and Nixon R. A. (2004) Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer’s disease. Int. J. Biochem. Cell Biol. 36, 25312540.
  • Yu W. H., Cuervo A. M., Kumar A. et al. (2005) Macroautophagy – a novel beta-amyloid peptide-generating pathway activated in Alzheimer’s disease. J. Cell Biol. 171, 8798.
  • Zhang X., Zhou K., Wang R., Cui J., Lipton S. A., Liao F. F., Xu H. and Zhang Y. W. (2007) Hypoxia inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem. 282, 1087310880.
  • Zhu X., Sun Z., Lee H. G., Siedlak S. L., Perry G. and Smith M. A. (2003) Distribution, levels, and activation of MEK1 in Alzheimer’s disease. J. Neurochem. 86, 136142.
  • Zhu X., Raina A. K., Perry G. and Smith M. A. (2004) Alzheimer’s disease: the two-hit hypothesis. Lancet Neurol. 3, 219226.